SecBot SecBot
SECBOTREPLAY Home › Report › TWST

TWST · CEO files 144 for 19K shares

Twist Bioscience Corp · 144 filed Nov 16, 2026 at 16:01 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 16, 2026 at 16:01 ET

CEO Emily M. Leproust filed a Form 144 notice of intent to sell 19,045 shares of Twist Bioscience common stock, valued at approximately $1.97 million, to cover a tax obligation from vested equity award settlement. The sale is routine and small relative to her prior trading activity and the company's market cap, carrying no material signal.

  • Insider: CEO Emily M. Leproust
  • Shares to be sold: 19,045 shares of common stock
  • Approximate value: $1,974,745.58
  • Sale date: November 16, 2026

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access